A
Alpa Laboratories Ltd Share Price
Pharmaceuticals
₹ (%)
- NSE
- BSE
What is Alpa Laboratories Ltd revenue and profit growth?
- BSE Code 532878
- NSE Symbol ALPA
- ISIN Demat INE385I01010
- Book Value (₹) 92.05
- Face Value (₹) 10.00
- Market Cap (₹ Cr.) 145.71
- P/E (TTM) 12.34
- EPS (TTM) 5.61
- Div Yield (%) 0.00
Is Alpa Laboratories Ltd financially strong enough to invest in?
Today’s Low
Today’s High
52W Low
52W High
Open
Prev. Close
Volume
What corporate actions has Alpa Laboratories Ltd announced recently?
Alpa Laboratories Limited - Shareholders meeting
Oct 01, 2025Alpa Laboratories Limited has submitted the Exchange a copy Srutinizers report of AGM held on September 29, 2025.
Alpa Laboratories Limited - Trading Window-XBRL
Mar 26, 2025ALPA LABORATORIES LIMITED has informed the Exchange about Closure of Trading Window
What is the history and background of Alpa Laboratories Ltd?
Mr. Purushottam R. Patel, Mr. M.S. Chawla and Mr. Pravin C. Shah, partners of M/s Alpa Laboratories, which was formed in the year 1967, incorporated a private limited company in the name of Alpa Laboratories Private Limited on March 18, 1988 for manufacture of pharmaceutical formulations. In the year 1998, Alpa Laboratories Private Limited was converted into a public limited company with effect from September 3, 1998 with the name of 'Alpa Laboratories Limited'.
In the year 1997, the company has initiated setting of a new manufacturing unit at Rau(Indore District), Madhya Pradesh. The unit commenced commercial production in the year 1999 of all types of formulations viz. Injectables (Vials/Ampoules both liquid and Dry), tablets, capsules, eye/ear drops, ointment and creams.
The company has manufacture a range of products such as ethical drugs, generic drugs, over the counter drugs (OTC) and veterinary products in various dosage forms and market them under the trade mark 'Alpa' which is a registered trademark in the name of Alpa Labs (India) Limited, a promoter group company. The company has also manufacture formulations for a number of other pharmaceutical companies of national and international repute such as Cipla, Zydus Cadila, Lupin, Glenmark, Genom Biotech, Jenburkt, etc. (under their own brands) located both in India and abroad in countries such as Philippines, Iran, Iraq, Sierra Leon, Madagascar, Kenya, Liberia, Puerto Rico, Haiti, Sudan, Ghana, Nigeria, Srilanka etc. Further, the company has also undertaken contract manufacturing of a large variety of pharmaceuticals.
The company has manufacture various dosage forms which include injectables (vials / ampoules both liquid and dry), tablets, capsules, eye / ear drops, ointment and creams and dry syrups. The company has an established product-marketing network covering both metro and mini metro cities, which enable company to reach the existing and potential customers through the network of distributors and dealers spread across the country. For the purpose of marketing the various products, the company's business has been categorized as Branded Generic Division, Veterinary Division, Exports Division and Contract Manufacturing Division.
| Founded | : 1988 |
| Chairman | : Mahendra Singh Chawla |
| Managing Director | : Paresh Chawla |
| Address | : 33/2 Pigdamber, A B Road Rau, Indore, Madhya Pradesh, 453446, |
| HO Tel | : 91-731-4294567 |
Open A Free Demat Account Today
Get StartedDocuments To Be Kept Handy
- PAN Card
- Cancelled Cheque
- Latest 6 month Bank Statement (Only for Derivatives Trading)